Skip NavigationSkip to Content

Polymeric Lipid Assemblies as Novel Theranostic Tools

  1. Author:
    Puri, A.
    Blumenthal, R.
  2. Author Address

    [Puri, A; Blumenthal, R] NCI, CCR Nanobiol Program, Frederick, MD 21702 USA.;Blumenthal, R (reprint author), NCI, CCR Nanobiol Program, Frederick, MD 21702 USA;blumenthalr@mail.nih.gov
    1. Year: 2011
    2. Date: Oct
  1. Journal: Accounts of Chemical Research
    1. 44
    2. 10
    3. Pages: 1071-1079
  2. Type of Article: Review
  3. ISSN: 0001-4842
  1. Abstract:

    Polymerizable lipids have been used in research and medical applications such as membrane models, imaging platforms, drug delivery systems, vaccine carriers, biosensors, and coating materials. The polymerization of these lipid molecules forms a covalent bond between lipid moieties, which improves the noncovalent interactions that maintain the lipid lamellar phase architecture and increases the stability of the polymerized system. Because such lipid molecules form nanoassemblies with modifiable structures that acquire the stability of polymers following covalent bond formation, these lipids are of considerable Interest in the emerging field of theranostics. In this Account, we summarize the biomedical applications of polymerizable lipids (primarily phospholipids) in the context of various nanoplatforms. We discuss stable nanoplatforms, which have been used in a variety of theranostics applications. In addition, we describe methods for assembling triggerable theranostics by combining appropriate nonpolymerizable lipids with polymerizable lipids. Polymeric lipids hold promise as nanotools in the field of medical imaging, targeting, and on-demand drug delivery. Because of their similarity to biological lipids, long-term toxicity issues from polymerizable lipid nanoplatforms are predicted to be minimal. Although the field of polymeric nanocapsules is still in development, intensive efforts are underway to produce systems which could be applied to disease diagnosis and treatment. We envision that nanoimaging platforms coupled with localized drug delivery technology will have a significant impact on cancer therapy and other related diseases. The existing wealth of clinical knowledge both in the photochemistry of imaging agents and/or drugs and modifications of these agents using light will prove valuable in the further development of polymeric theranostic lipid-based nanoparticles.

    See More

External Sources

  1. DOI: 10.1021/ar2001843
  2. WOS: 000296682400024

Library Notes

  1. Fiscal Year: FY2011-2012
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel